Skip to content

Released Aug 6, 2024, before the open

10-Q filed Aug 6, 2024, 37 days after period end · 0000950170-24-091200

Q2 2024 · 10-Q
Revenue$198.62M+6.2% vs Q2 2023+5.3% vs Q1 2024
Net Income-$33.44MN/M vs Q2 2023N/M vs Q1 2024
EPS Diluted-$0.88N/M vs Q2 2023N/M vs Q1 2024
Gross Profit$134,749,000+12.7%
Operating Income-$24,906,000N/M
Operating Cash Flowderived$8,984,000N/M
Free Cash Flowderived-$360,000N/M
Margins · derived
Gross margin67.8%+3.9 pt vs Q2 2023
Operating margin-12.5%+7.0 pt vs Q2 2023
Net margin-16.8%+4.2 pt vs Q2 2023

What the release said

The release

Same quarter

MetricQ2 2024Q2 2023Q2 2022Q2 2021
Revenue$198.62M$187.02M$118.07M$121.39M
Net Income-$33.44M-$39.43M$2.49M$2.42M
EPS Diluted-$0.88-$1.07$0.12$0.12

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR